InsidersTradesSigma
Total declarations
Company
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
7
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Fine N Scott, Chairman & CEO. Insider active across 1 company, notably Cyclo Therapeutics, Inc.. Cumulatively, 8 reports have been recorded. Split: 7 buys · 0 sell. Total volume traded: €332k. History available since 15 September 2021. The latest transaction was disclosed on 20 October 2023 (X). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Fine N Scott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
299,402 shares@ US$0.7129.9% of flowCommon StockSEC:0001437749-23-028700:0
299,402 shares@ US$0.7128.9% of flowCommon StockSEC:0001437749-23-010877:0
Canonical exit: 19 Jul 2023 (T+90)
10,334 shares@ US$3.586.1% of flowCommon StockSEC:0001437749-22-002613:0
Canonical exit: 8 May 2022 (T+90)
5,000 shares@ US$3.893.2% of flowCommon StockSEC:0001437749-22-001188:0
Canonical exit: 19 Apr 2022 (T+90)
5,000 shares@ US$3.893.2% of flowCommon StockSEC:0001437749-21-028622:0
Canonical exit: 15 Mar 2022 (T+90)
5,000 shares@ US$4.934.1% of flowCommon StockSEC:0001437749-21-027709:0
Canonical exit: 2 Mar 2022 (T+90)
5,000 shares@ US$5.254.3% of flowCommon StockSEC:0001437749-21-027140:0
Canonical exit: 17 Feb 2022 (T+90)
5,000 shares@ US$6.355.0% of flowCommon StockSEC:0001437749-21-022183:0
Canonical exit: 14 Dec 2021 (T+90)
8 of 8 declarations
About Fine N Scott
FINE N SCOTT is Président-Directeur Général and Chief Executive Officer of Cyclo Therapeutics, Inc. Across 8 filings, the sampled filings run from 2021-09-15 to 2023-10-23, with EUR 332226 of buys and EUR 0 of sells, and the modal transaction nature is Acquisition.
